Abstract
Exogenous ochronosis (EO) can be an unintended psychologically troubling condition for patients who are already being treated for longer-term hyperpigmentation disorders such as melasma. Early diagnosis is key in order that the offending agent can be stopped to prevent further disfiguring discoloration. EO can be diagnosed in the right clinical setting with the aid of dermatoscopy, which can assist in early diagnosis and may negate the need for a biopsy. Laser modalities using Q-switched lasers of longer wavelengths and combination laser dermabrasion treatments have shown the most significant results with minimal adverse events. However, further large-scale studies are needed to determine optimal treatment modalities. Although considered uncommon, the incidence of EO will likely continue to increase with the growth of immigrant populations and the use of skin-lightening agents above the FDA’s recommended over-the-counter concentrations, without the guidance of a dermatologist.
Similar content being viewed by others
References
Findlay GH. Ochronosis. Clin Dermatol. 1989;7(2):28–35.
Mistry JB, Bukhari M, Taylor AM. Alkaptonuria. Rare Dis. 2013;1:e27475.
Beddard AP, Plumtre CM. A further note on ochronosis associated with carboluria. Q S Med. 1912;5:505–7.
Charlin R, Barcaui CB, Kac BK, Soares DB, Rabello-Fonseca R, Azulay-Abulafia L. Hydroquinone-induced exogenous ochronosis: a report of four cases and usefulness of dermoscopy. Int J Dermatol. 2008;47(1):19–23.
Penneys NS. Ochronosis like pigmentation from hydroquinone bleaching creams. Arch Dermatol. 1985;121(10):1239–40.
Findlay GH, Morrison JG, Simson IW. Exogenous ochronosis and pigmented colloid milium from hydroquinone bleaching creams. Br J Dermatol. 1975;93(6):613–22.
Levin CY, Maibach H. Exogenous ochronosis. An update on clinical features, causative agents and treatment options. Am J Clin Dermatol. 2001;2(4):213–7.
Dogliotti M, Leibowitz M. Granulomatous ochronosis: a cosmetic-induced skin disorder in Blacks. S Afr Med J. 1979;56(19):757–60.
Jacyk WK. Annular granulomatous lesions in exogenous ochronosis are manifestation of sarcoidosis. Am J Dermatopathol. 1995;17(1):18–22.
Khunger N, Kandhari R. Dermoscopic criteria for differentiating exogenous ochronosis from melasma. Indian J Dermatol Venereol Leprol. 2013;79(6):819–21.
Liu WC, Tey HL, Lee JS, Goh BK. Exogenous ochronosis in a Chinese patient: use of dermoscopy aids early diagnosis and selection of biopsy site. Singapore Med J. 2014;55(1):e1–3.
Gil I, Segura S, Martinez-Escala E, Lloreta J, Puig S, Velez M, et al. Dermoscopic and reflectance confocal microscopic features of exogenous ochronosis. Arch Dermatol. 2010;146(9):1021–5.
Cullison D, Abele DC, O’Quinn JL. Localized exogenous ochronosis. J Am Acad Dermatol. 1983;8(6):882–9.
Zawar V, Tan S-K. Exogenous ochronosis: a review for clinicians. Expert Rev Dermatol. 2012;7(2):171–80.
US FDA. Docket no. 78N-0065; comments PRT 4 and PRT 5. US FDA; 1998.
US Census Bureau. US Census Bureau projections show a slower growing, older, more diverse nation a half century from now. 12 Dec 2012. Available at: https://www.census.gov/newsroom/releases/archives/population/cb12-243.html.
Galindo GR, Mayer JA, Slymen D, Almaguer DD, Clapp E, Pichon LC, et al. Sun sensitivity in 5 US ethnoracial groups. Cutis. 2007;80(1):25–30.
Werlinger KD, Guevara IL, Gonzalez CM, Rincon ET, Caetano R, Haley RW, et al. Prevalence of self-diagnosed melasma among premenopausal Latino women in Dallas and Fort Worth, Tex. Arch Dermatol. 2007;143(3):424–5.
Sivayathorn A. Melasma in orientals. Clin Drug Invest. 1995;10(Suppl 2):34.
Tan SK. Exogenous ochronosis in ethnic Chinese Asians: a clinicopathological study, diagnosis and treatment. J Eur Acad Dermatol Venereol. 2011;25(7):842–50.
Bruce S, Tschen JA, Chow D. Exogenous ochronosis resulting from quinine injections. J Am Acad Dermatol. 1986;15(2 Pt 2):357–61.
Ribas J, Schettini AP. Cavalcante Mde S. Exogenous ochronosis hydroquinone induced: a report of four cases. An Bras Dermatol. 2010;85(5):699–703.
Olumide YM, Akinkugbe AO, Altraide D, Mohammed T, Ahamefule N, Ayanlowo S, et al. Complications of chronic use of skin lightening cosmetics. Int J Dermatol. 2008;47(4):344–53.
Andersen FA, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, et al. Final amended safety assessment of hydroquinone as used in cosmetics. Int J Toxicol. 2010;29(6 Suppl):274S–87S.
Levitt J. The safety of hydroquinone: a dermatologist’s response to the 2006 Federal Register. J Am Acad Dermatol. 2007;57(5):854–72.
Jow T, Hantash BM. Hydroquinone-induced depigmentation: case report and review of the literature. Dermatitis. 2014;25(1):e1–5.
Diven DG, Smith EB, Pupo RA, Lee M. Hydroquinone-induced localized exogenous ochronosis treated with dermabrasion and CO2 laser. J Dermatol Surg Oncol. 1990;16(11):1018–22.
Singh A, Ramesh V. Exogenous ochronosis. Indian J Med Res. 2014;139:327.
Schulz EJ, Summers B, Summers RS. Inappropriate treatment of cosmetic ochronosis with hydroquinone. S Afr Med J. 1988;73(1):59–60.
Camarasa JG, Serra-Baldrich E. Exogenous ochronosis with allergic contact dermatitis from hydroquinone. Contact Dermatitis. 1994;31(1):57–8.
Howard KL, Furner BB. Exogenous ochronosis in a Mexican–American woman. Cutis. 1990;45(3):180–2.
Lawrence N, Bligard CA, Reed R, Perret WJ. Exogenous ochronosis in the United States. J Am Acad Dermatol. 1988;18(5 Pt 2):1207–11.
Martin RF, Sanchez JL, Gonzalez A, Lugo-Somolinos A, Ruiz H. Exogenous ochronosis. P R Health Sci J. 1992;11(1):23–6.
Lang PG Jr. Probable coexisting exogenous ochronosis and mercurial pigmentation managed by dermabrasion. J Am Acad Dermatol. 1988;19(5 Pt 2):942–6.
Hoshaw RA, Zimmerman KG, Menter A. Ochronosis like pigmentation from hydroquinone bleaching creams in American blacks. Arch Dermatol. 1985;121(1):105–8.
Fisher AA. Tetracycline treatment for sarcoid-like ochronosis due to hydroquinone. Cutis. 1988;42(1):19–20.
Moche MJ, Glassman SJ, Modi D, Grayson W. Cutaneous annular sarcoidosis developing on a background of exogenous ochronosis: a report of two cases and review of the literature. Clin Exp Dermatol. 2010;35(4):399–402.
Bellew SG, Alster TS. Treatment of exogenous ochronosis with a Q-switched alexandrite (755 nm) laser. Dermatol Surg. 2004;30(4 Pt 1):555–8.
Chaptini C, Huilgol SC. Erbium-doped yttrium aluminium garnet ablative laser treatment for endogenous ochronosis. Australas J Dermatol. doi:10.1111/ajd.12199. Epub 10 Oct 2014.
Kramer KE, Lopez A, Stefanato CM, Phillips TJ. Exogenous ochronosis. J Am Acad Dermatol. 2000;42(5 Pt 2):869–71.
Lee MD, Weiss E. Treatment of exogenous ochronosis with advanced fluorescence technology. Dermatol Surg. 2014;40(9):1046–8.
Tan SK. Exogenous ochronosis: successful outcome after treatment with Q-switched Nd:YAG laser. J Cosmet Laser Ther. 2013;15(5):274–8.
Romero SA, Pereira PM, Mariano AV, Francesconi F, Francesconi VA. Use of dermoscopy for diagnosis of exogenous ochronosis. An Bras Dermatol. 2011;86(4 Suppl 1):S31–4.
Kanechorn-Na-Ayuthaya P, Niumphradit N, Aunhachoke K, Nakakes A, Sittiwangkul R, Srisuttiyakorn C. Effect of combination of 1064 nm Q-switched Nd:YAG and fractional carbon dioxide lasers for treating exogenous ochronosis. J Cosmet Laser Ther. 2013;15(1):42–5.
Acknowledgments
Brian J. Simmons, Robert D. Griffith, Fleta N. Bray, Leyre A. Falto-Aizpurua, and Keyvan Nouri have no conflicts of interest to declare. No funding was used in the design and conduct of the study, collection, management, analysis and interpretation of data, preparation, review or approval of the manuscript, or in the decision to submit the manuscript for publication.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Simmons, B.J., Griffith, R.D., Bray, F.N. et al. Exogenous Ochronosis: A Comprehensive Review of the Diagnosis, Epidemiology, Causes, and Treatments. Am J Clin Dermatol 16, 205–212 (2015). https://doi.org/10.1007/s40257-015-0126-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40257-015-0126-8